LDB3 p.Ala177=
c.531C>T · rs776893998 · VCV1110807
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -0.64 | GERP -3.9 |
| Overall | ||
| CADD | 2.439 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 0.0307% | 3,252 |
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,478 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- LDB3
- Protein
- p.Ala177=
- Coding
- c.531C>T
- MANE Select
- NM_007078
- dbSNP
- rs776893998
- Type
- single nucleotide variant
- Location
- chr10:86681645 (GRCh38)
- Gene constraint
- LOEUF 0.864 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 61.98 · 2 PDB
- Residue 177
- the 'disordered' region
Disease context
myofibrillar myopathy 4 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Late-onset distal myopathy, Markesbery-Griggs type (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Adult
- Prevalence
- <1 / 1 000 000 (Worldwide)
Similar variants
- LDB3 p.Ala177Val Conflicting classifications of pathogenicity ★ ⚠ same residue
- LDB3 p.Ala177fs Conflicting classifications of pathogenicity ★ same residue
- LDB3 p.Ala177Asp Uncertain significance ⚠ same residue
- LDB3 p.Ala147Thr Pathogenic/Likely pathogenic ★★ same condition
- LDB3 p.Ala165Val Pathogenic/Likely pathogenic ★★ same condition
- LDB3 c.1231+4A>C Uncertain significance ★★ same condition
- LDB3 c.1858-11C>A Uncertain significance ★★ same condition
- LDB3 c.246-3C>T Uncertain significance ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ldb3-p-ala177 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown